BCWORLD PHARM. Co. Ltd (200780) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.43 Billion ≈ $968.52K USD) by net assets (₩72.50 Billion ≈ $49.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

BCWORLD PHARM. Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how BCWORLD PHARM. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 200780 total liabilities for a breakdown of total debt and financial obligations.

BCWORLD PHARM. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
MPC Energy Solutions NV
OL:MPCES
0.002x
Green Critical Minerals Ltd
AU:GCM
-0.032x
Heeros Oyj
HE:HEEROS
0.475x
D P Wires Limited
NSE:DPWIRES
0.208x
HLscience Co. Ltd
KQ:239610
-0.023x
Focus Graphite Inc
V:FMS
2.166x
Carbochim SA
RO:CBC
N/A
Central Motek Co Ltd
KO:308170
-0.050x

Annual Cash Flow Conversion Efficiency for BCWORLD PHARM. Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of BCWORLD PHARM. Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market value of BCWORLD PHARM. Co. Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩76.67 Billion
≈ $51.96 Million
₩4.04 Billion
≈ $2.74 Million
0.053x -60.64%
2023-12-31 ₩81.64 Billion
≈ $55.33 Million
₩10.94 Billion
≈ $7.41 Million
0.134x +54.84%
2022-12-31 ₩79.55 Billion
≈ $53.91 Million
₩6.88 Billion
≈ $4.66 Million
0.087x +1237.07%
2021-12-31 ₩81.46 Billion
≈ $55.20 Million
₩-619.83 Million
≈ $-420.05K
-0.008x +85.94%
2020-12-31 ₩101.69 Billion
≈ $68.92 Million
₩-5.50 Billion
≈ $-3.73 Million
-0.054x -143.45%
2019-12-31 ₩97.24 Billion
≈ $65.90 Million
₩12.11 Billion
≈ $8.21 Million
0.125x +110.10%
2018-12-31 ₩90.09 Billion
≈ $61.05 Million
₩5.34 Billion
≈ $3.62 Million
0.059x -39.05%
2017-12-31 ₩81.23 Billion
≈ $55.05 Million
₩7.90 Billion
≈ $5.35 Million
0.097x +2848.61%
2016-12-31 ₩73.88 Billion
≈ $50.06 Million
₩243.66 Million
≈ $165.13K
0.003x -97.47%
2015-12-31 ₩67.40 Billion
≈ $45.68 Million
₩8.78 Billion
≈ $5.95 Million
0.130x --

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General
Market Cap
$30.55 Million
₩45.09 Billion KRW
Market Cap Rank
#23644 Global
#1696 in Korea
Share Price
₩4410.00
Change (1 day)
-0.79%
52-Week Range
₩4210.00 - ₩5870.00
All Time High
₩30700.49
About

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberc… Read more